Publications by authors named "Randy Bradley"
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we show the results of a multi-institutional retrospective analysis of 1,152 patients (596 African-American men (AAM) and 556 European-American men (EAM)) who underwent radical prostatectomy. Comparative analyses between the race groups were conducted at the clinical, genomic, pathway, molecular subtype, and prognostic levels.
View Article and Find Full Text PDFBackground: Current clinical nomograms such as American Urological Association/National Comprehensive Cancer Network (AUA/NCCN) risk categories or CAPRA may not always reflect prostate cancer (PCa) risk among African American men. We evaluated the usefulness of adding a commercially available cell cycle progression (CCP) score to improve risk stratification in a community-based African American population.
Methods: Biopsy tissues from 150 African American and 60 Caucasian men were obtained from a single community urologic oncology practice in Memphis, TN.
Article Synopsis
- The study aimed to evaluate how a resident physician educational program in a pediatric emergency department impacts pharmacy interventions and reduces medication errors, including dose adjustments and adverse drug events.
- During a 9-month period, the ED pharmacist tracked interventions and errors across three phases: pre-observational, observational, and interventional, with significant findings analyzed statistically.
- Results showed a notable decrease in dose adjustments and order clarifications after the program, along with a positive response from residents and ED staff, indicating increased awareness and pharmacist involvement.